These therapeutic approaches have demonstrated a reinvigoration of pre-existing tumor-specific T cells, augmentation in the infiltration of CD8+ T cells, and ultimately the induction of tumor suppression [39, 41, 42]. This evidence concerns the gene CD8A and neoplasm.